tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sagimet Biosciences announces license partner Ascletis issues results for ASC40
PremiumThe FlySagimet Biosciences announces license partner Ascletis issues results for ASC40
11d ago
Multiple Shots on Goal: Sagimet’s Differentiated MASH Combo and Acne Franchise Underpin Buy Rating and Favorable Risk‑Reward
Premium
Ratings
Multiple Shots on Goal: Sagimet’s Differentiated MASH Combo and Acne Franchise Underpin Buy Rating and Favorable Risk‑Reward
12d ago
Sagimet Biosciences initiated with an Equal Weight at Barclays
Premium
The Fly
Sagimet Biosciences initiated with an Equal Weight at Barclays
17d ago
Strategic Licensing and Pipeline Advancements Drive Buy Rating for Sagimet Biosciences
PremiumRatingsStrategic Licensing and Pipeline Advancements Drive Buy Rating for Sagimet Biosciences
2M ago
Sagimet Biosciences enters global license agreement with TAPI
Premium
Company Announcements
Sagimet Biosciences enters global license agreement with TAPI
2M ago
Sagimet Biosciences announces China’s NMPA accepted NDA for denifanstat
Premium
The Fly
Sagimet Biosciences announces China’s NMPA accepted NDA for denifanstat
2M ago
Sagimet Biosciences Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsSagimet Biosciences Reports Q3 2025 Financial Results
3M ago
Optimistic Buy Rating for Sagimet Biosciences Driven by Promising Clinical Progress and Strong Financial Position
Premium
Ratings
Optimistic Buy Rating for Sagimet Biosciences Driven by Promising Clinical Progress and Strong Financial Position
3M ago
Sagimet Biosciences Reports Q3 Results and Updates
Premium
Company Announcements
Sagimet Biosciences Reports Q3 Results and Updates
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100